← Back to Search

Device

tDCS for Chronic Pain in Aging Workers

N/A
Recruiting
Led By Guillaume Leonard, PhD
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
To be more than 55 years old
Be older than 18 years old
Must not have
tDCS contraindications (epilepsy, metallic implant in the head, pacemaker, cochlear implant)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, about 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a treatment called tDCS, which uses a small electrical current applied to the head to help reduce pain. It focuses on older workers who suffer from chronic pain, aiming to help them stay employed. The treatment works by changing how the brain processes pain, making it feel less intense. tDCS is a non-invasive brain stimulation technique that has shown promise in reducing pain sensitivity and improving pain management in various clinical studies.

Who is the study for?
This trial is for individuals over 55 who suffer from chronic pain that affects their work. Participants must be currently employed. Those with epilepsy, metallic head implants, pacemakers, or cochlear implants cannot join due to risks associated with the treatment.
What is being tested?
The study tests transcranial direct current stimulation (tDCS) as a method to reduce chronic pain in older workers. It compares two protocols: one with 5 sessions and an enhanced one with 11 sessions, aiming to see which is more effective for pain relief and work retention.
What are the potential side effects?
Potential side effects of tDCS may include mild discomfort at the site of electrode placement, itching or tingling during the session, fatigue, headache, nausea or insomnia post-treatment. These are generally mild and temporary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 55 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I don't have epilepsy, a metallic head implant, pacemaker, or cochlear implant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, about 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, about 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Anxiety
Central sensitization
Depression
+5 more
Secondary study objectives
Intervention
Recruitment
Security

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard protocolExperimental Treatment1 Intervention
5 tDCS sessions in 1 week
Group II: Enhanced protocolExperimental Treatment1 Intervention
11 tDCS sessions devised in 4 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
transcranial direct current stimulation
2013
Completed Phase 3
~1430

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
304 Previous Clinical Trials
76,705 Total Patients Enrolled
11 Trials studying Chronic Pain
1,124 Patients Enrolled for Chronic Pain
CISSS Abitibi-TémiscamingueUNKNOWN
Guillaume Leonard, PhDPrincipal InvestigatorUniversité de Sherbrooke
2 Previous Clinical Trials
78 Total Patients Enrolled
2 Trials studying Chronic Pain
78 Patients Enrolled for Chronic Pain

Media Library

Transcranial Direct Current Stimulation (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05370833 — N/A
Chronic Pain Research Study Groups: Standard protocol, Enhanced protocol
Chronic Pain Clinical Trial 2023: Transcranial Direct Current Stimulation Highlights & Side Effects. Trial Name: NCT05370833 — N/A
Transcranial Direct Current Stimulation (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05370833 — N/A
~7 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top